- Home
- ARW vs BBIO Comparison
ARW vs BBIO Comparison
Compare ARW & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARW
- BBIO
- Stock Information
- Founded
- ARW 1935
- BBIO 2015
- Country
- ARW United States
- BBIO United States
- Employees
- ARW N/A
- BBIO N/A
- Industry
- ARW Electronic Components
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ARW Technology
- BBIO Health Care
- Exchange
- ARW Nasdaq
- BBIO Nasdaq
- Market Cap
- ARW 6.9B
- BBIO 4.7B
- IPO Year
- ARW N/A
- BBIO 2019
- Fundamental
- Price
- ARW $136.77
- BBIO $26.19
- Analyst Decision
- ARW Hold
- BBIO Strong Buy
- Analyst Count
- ARW 4
- BBIO 13
- Target Price
- ARW $130.75
- BBIO $46.83
- AVG Volume (30 Days)
- ARW 390.5K
- BBIO 1.9M
- Earning Date
- ARW 10-31-2024
- BBIO 10-31-2024
- Dividend Yield
- ARW N/A
- BBIO N/A
- EPS Growth
- ARW N/A
- BBIO N/A
- EPS
- ARW 10.63
- BBIO N/A
- Revenue
- ARW $29,673,304,000.00
- BBIO $219,124,000.00
- Revenue This Year
- ARW N/A
- BBIO $4,080.05
- Revenue Next Year
- ARW $4.89
- BBIO N/A
- P/E Ratio
- ARW $12.88
- BBIO N/A
- Revenue Growth
- ARW N/A
- BBIO 3761.22
- 52 Week Low
- ARW $108.51
- BBIO $21.62
- 52 Week High
- ARW $137.39
- BBIO $44.32
- Technical
- Relative Strength Index (RSI)
- ARW 60.13
- BBIO 53.03
- Support Level
- ARW $131.48
- BBIO $25.16
- Resistance Level
- ARW $136.50
- BBIO $26.78
- Average True Range (ATR)
- ARW 2.10
- BBIO 1.17
- MACD
- ARW 0.31
- BBIO 0.19
- Stochastic Oscillator
- ARW 87.89
- BBIO 85.36
About ARW Arrow Electronics Inc.
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology.